-
What is CDE's consideration for the review of changes to drug clinical trial protocols? Here comes the guide
Time of Update: 2022-11-14
In order to improve the quality of the applicant's preparation of clinical trial protocols, standardize the communication and exchange of clinical trial protocols and various registration application
-
Pharmaceutical grade propylene glycol 25kg mixed with fatty acid glycerides 36 type
Time of Update: 2022-10-01
Pharmaceutical grade propylene glycol 25kg mixed fatty acid glycerides 36 pharmaceutical grade propylene glycol 25kg mixed fatty acid glycerol ester 36 type propylene glycol Bing'erchun Propylene Glyc
-
The child's growth and development are lagging behind, neither looking up nor turning over. Through genetic testing, he was diagnosed with Menkes
Time of Update: 2022-09-09
" ”The above-mentioned industry insiders also told the Times Weekly reporter, "Xu Wei's experience affects other rare disease patients and family members, and they may also contact pharmaceutical companies to develop genetic drugs.
-
Traditional Chinese medicine has a lot of room for growth in the future, and mergers and acquisitions are being staged in the industry
Time of Update: 2022-08-15
8824% stake in Hangzhou Huqingyutang, a traditional Chinese medicine company held by Yuanjin Health with its own funds of 215 million yuan For another example, Jingxin Pharmaceutical announced on June 10 that the company acquired a 5.
-
The traditional Chinese medicine sector changed again, and 2 stocks rose by the daily limit
Time of Update: 2022-05-07
2 individual stocks daily limit Northeast Pharmaceuticals opened at 5.
It can be found that most of the obvious stock price changes today are companies whose main business is engaged in related traditional Chinese medicine .
-
The peptide drug market has broad prospects, but it still faces 3 major challenges
Time of Update: 2022-05-02
Compared with small molecules, the development of peptide drugs is more complicated, and the company may not be able to meet the challenges by itself, and it needs to cooperate with other companies at different stages .
At present, domestic companies in the CDMO field of peptide drugs include Ambio Pharmaceuticals, Sino Bio, Nuotai Bio, Asymchem, etc.
-
After 1 billion oral hypoglycemic drug Hausen, Sichuan pharmaceutical companies also entered the market
Time of Update: 2022-01-02
Figure 1: The status of companies reporting for the production of dapagliflozin tablets recentlySource: CDE official websiteDapagliflozin is a new oral hypoglycemic drug developed by Bristol-Myers Squibb (which has been transferred to AstraZeneca).
-
Children's medicine welcomes the policy dividend again, and the market space is becoming wider and wider
Time of Update: 2021-12-06
Under the policy-guided research and development of children's drugs and the liberalization of the "three-child policy", the industry predicts that the market size of children's drugs will continue to maintain an average annual growth rate of more than double digits for a long time to come .
-
The Biden administration initiated the drug price negotiation bill. The CEOs all voiced that the US prescription drug prices will be reduced
Time of Update: 2021-10-23
The bill triggered strong opposition from the pharmaceutical industry, including CEOs of companies such as AbbVie, BMS, Eli Lilly, and GSK, all expressed concern or even opposition to this increase in control of drug pricing .
-
Hebei Provincial Drug Administration issued a document to abolish distance and area restrictions on pharmacies
Time of Update: 2021-08-27
According to the "Notice on Optimizing the Approval of the Establishment of Pharmacies" (hereinafter referred to as the "Notice") issued by the Hebei Provincial Drug Administration recently, it is necessary to continue to optimize the approval services for the establishment of pharmacies, and to cancel the requirements for the set distance and business area of pharmaceutical retail companies.
-
Many companies actively recall related illegal medical device products
Time of Update: 2021-08-09
) has voluntarily recalled the steel and nickel-titanium root canal instrument Mani NRT FellerMani (Beijing) Trading Co.
) has voluntarily recalled the steel and nickel-titanium mechanical root canal instrument Mani NRT Fur (registration number: National Machinery Injection 20152172611) .
-
With a shortage guarantee mechanism, why is there still a "drug shortage" for cheap life-saving drugs
Time of Update: 2021-08-07
A person in charge of a dapsone tablet manufacturer said that the current supply cost of raw materials is relatively high.
-
Inventory of multinational pharmaceutical companies in 2020: Johnson & Johnson firmly ranks C, Novartis's pharmaceutical business is No. 1 in the world, and Humira is still the "king
Time of Update: 2021-07-19
Affected by mergers and acquisitions, AbbVie became the top three companies in the pharmaceutical business revenue, and BMS ranked sixth in the world.
-
Intensive anti-corruption efforts in the pharmaceutical field make new cuts to falsely high drug prices
Time of Update: 2021-05-10
The "two-invoice system" for the purchase and sale of medicines makes intermediate price increases impossible and can cut the middle chain of medicine corruption.
If the two incidents are linked together, it shows that the intensity of punishment of medical corruption is increasing and the means are more abundant.
-
Well-known pharmaceutical companies have abolished their sales teams
Time of Update: 2021-03-12
Mharma representatives how to deal with the professional test of the above-mentioned people to SaibaiLan said that the reason why more and more pharmaceutical companies began to choose to give varieties to agents to do, mainly because a team of agents can operate multiple varieties at the same time, can accept the situation of profit compression, compared to the enterprise self-built sales team, the cost is relatively small.